At 4 weeks after transplant, there was a statistically significant 66% reduction in percentage of CD4+CD8+ T-ALL blasts in the blood of doxycycline-treated mice in contrast to placebo-treated mice (Fig. 6A, B). The gene discussed is CD8A; the disease is acute lymphoblastic leukemia.